A Trial in Healthy Adult Participants and Adults With Autoimmune Disease to Test How HBM7020 is Tolerated and Absorbed in the Body

NCT07649265 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

63

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis
Systemic Lupus Erythematosus
Systemic Sclerosis
Sjögren's Disease

Interventions

DRUG: HBM7020

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.